The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Aptamers Industry" - https://www.reportlinker.com/p05797918/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Aptamers Market to Reach $477.9 Million by 2030

In the changed post COVID-19 business landscape, the global market for Aptamers estimated at US$146.5 Million in the year 2022, is projected to reach a revised size of US$477.9 Million by 2030, growing at a CAGR of 15.9% over the analysis period 2022-2030. DNA Aptamers, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$227.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the XNA Aptamers segment is readjusted to a revised 16.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $39.9 Million, While China is Forecast to Grow at 21.3% CAGR

The Aptamers market in the U.S. is estimated at US$39.9 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$115.1 Million by the year 2030 trailing a CAGR of 21.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.8% and 13.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$74.8 Million by the year 2030.

Select Competitors (Total 12 Featured)
- AM Biotechnologies, LLC
- Aptagen, LLC
- Aptamer Group
- Aptamer Sciences Inc.
- Aptus Biotech
- Base Pair Biotechnologies, Inc.
- NeoVentures Biotechnology Inc.
- SomaLogic, Inc.
- TriLink BioTechnologies, LLC.
- Vivonics, Inc.


Read the full report: https://www.reportlinker.com/p05797918/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
An Overview Aptamers
Aptamers - Advances and Discoveries
Aptamers - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Aptamers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 2: World 8-Year Perspective for Aptamers by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets for Years 2023 & 2030

Table 3: World Recent Past, Current & Future Analysis for SELEX
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 4: World 8-Year Perspective for SELEX by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2023 & 2030

Table 5: World Recent Past, Current & Future Analysis for Other
Technologies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 6: World 8-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 8: World 8-Year Perspective for Diagnostics by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2023 & 2030

Table 9: World Recent Past, Current & Future Analysis for Other
End-Uses by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 10: World 8-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 11: World Aptamers Market Analysis of Annual Sales in US$
for Years 2014 through 2030

Table 12: World Recent Past, Current & Future Analysis for DNA
Aptamers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 13: World 8-Year Perspective for DNA Aptamers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 14: World Recent Past, Current & Future Analysis for XNA
Aptamers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 15: World 8-Year Perspective for XNA Aptamers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for RNA
Aptamers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 17: World 8-Year Perspective for RNA Aptamers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 18: World Recent Past, Current & Future Analysis for
Therapeutics Development by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ for Years 2022 through 2030 and % CAGR

Table 19: World 8-Year Perspective for Therapeutics Development
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 20: World Recent Past, Current & Future Analysis for
Research & Development by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ for Years 2022 through 2030 and % CAGR

Table 21: World 8-Year Perspective for Research & Development
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
for Years 2022 through 2030 and % CAGR

Table 23: World 8-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 24: World Recent Past, Current & Future Analysis for
Pharma & Biotech Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ for Years 2022 through 2030 and % CAGR

Table 25: World 8-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2023 & 2030

Table 26: World Recent Past, Current & Future Analysis for
Academic & Government Research Institutes by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2022 through 2030 and % CAGR

Table 27: World 8-Year Perspective for Academic & Government
Research Institutes by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2023 (E)
Table 28: USA Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 29: USA 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 30: USA Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 31: USA 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 32: USA Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 33: USA 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 34: USA Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 35: USA 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

CANADA
Table 36: Canada Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 37: Canada 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 38: Canada Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 39: Canada 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 40: Canada Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 41: Canada 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 42: Canada Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 43: Canada 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

JAPAN
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2023 (E)
Table 44: Japan Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 45: Japan 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 46: Japan Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 47: Japan 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 48: Japan Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 49: Japan 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 50: Japan Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 51: Japan 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

CHINA
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2023 (E)
Table 52: China Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 53: China 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 54: China Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 55: China 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 56: China Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 57: China 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 58: China Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 59: China 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

EUROPE
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2023 (E)
Table 60: Europe Recent Past, Current & Future Analysis for
Aptamers by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ for Years 2022 through 2030 and % CAGR

Table 61: Europe 8-Year Perspective for Aptamers by Geographic
Region - Percentage Breakdown of Value Sales for France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
for Years 2023 & 2030

Table 62: Europe Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 63: Europe 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 64: Europe Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 65: Europe 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 66: Europe Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 67: Europe 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 68: Europe Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 69: Europe 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

FRANCE
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2023 (E)
Table 70: France Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 71: France 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 72: France Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 73: France 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 74: France Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 75: France 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 76: France Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 77: France 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

GERMANY
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2023 (E)
Table 78: Germany Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 79: Germany 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 80: Germany Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 81: Germany 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 82: Germany Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 83: Germany 8-Year Perspective for Aptamers by
Application - Percentage Breakdown of Value Sales for
Therapeutics Development, Research & Development, Diagnostics
and Other Applications for the Years 2023 & 2030

Table 84: Germany Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 85: Germany 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

ITALY
Table 86: Italy Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 87: Italy 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 88: Italy Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 89: Italy 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 90: Italy Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 91: Italy 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 92: Italy Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 93: Italy 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

UNITED KINGDOM
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2023 (E)
Table 94: UK Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 95: UK 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 96: UK Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 97: UK 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 98: UK Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 99: UK 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 100: UK Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 101: UK 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

SPAIN
Table 102: Spain Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 103: Spain 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 104: Spain Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 105: Spain 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 106: Spain Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 107: Spain 8-Year Perspective for Aptamers by Application -
Percentage Breakdown of Value Sales for Therapeutics
Development, Research & Development, Diagnostics and Other
Applications for the Years 2023 & 2030

Table 108: Spain Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 109: Spain 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

RUSSIA
Table 110: Russia Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 111: Russia 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 112: Russia Recent Past, Current & Future Analysis for
Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 113: Russia 8-Year Perspective for Aptamers by Technology -
Percentage Breakdown of Value Sales for SELEX and Other
Technologies for the Years 2023 & 2030

Table 114: Russia Recent Past, Current & Future Analysis for
Aptamers by Application - Therapeutics Development, Research &
Development, Diagnostics and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 115: Russia 8-Year Perspective for Aptamers by
Application - Percentage Breakdown of Value Sales for
Therapeutics Development, Research & Development, Diagnostics
and Other Applications for the Years 2023 & 2030

Table 116: Russia Recent Past, Current & Future Analysis for
Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 117: Russia 8-Year Perspective for Aptamers by End-Use -
Percentage Breakdown of Value Sales for Pharma & Biotech
Companies, Academic & Government Research Institutes and Other
End-Uses for the Years 2023 & 2030

REST OF EUROPE
Table 118: Rest of Europe Recent Past, Current & Future
Analysis for Aptamers by Type - DNA Aptamers, XNA Aptamers and
RNA Aptamers - Independent Analysis of Annual Sales in US$ for
the Years 2022 through 2030 and % CAGR

Table 119: Rest of Europe 8-Year Perspective for Aptamers by
Type - Percentage Breakdown of Value Sales for DNA Aptamers,
XNA Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 120: Rest of Europe Recent Past, Current & Future
Analysis for Aptamers by Technology - SELEX and Other
Technologies - Independent Analysis of Annual Sales in US$ for
the Years 2022 through 2030 and % CAGR

Table 121: Rest of Europe 8-Year Perspective for Aptamers by
Technology - Percentage Breakdown of Value Sales for SELEX and
Other Technologies for the Years 2023 & 2030

Table 122: Rest of Europe Recent Past, Current & Future
Analysis for Aptamers by Application - Therapeutics
Development, Research & Development, Diagnostics and Other
Applications - Independent Analysis of Annual Sales in US$ for
the Years 2022 through 2030 and % CAGR

Table 123: Rest of Europe 8-Year Perspective for Aptamers by
Application - Percentage Breakdown of Value Sales for
Therapeutics Development, Research & Development, Diagnostics
and Other Applications for the Years 2023 & 2030

Table 124: Rest of Europe Recent Past, Current & Future
Analysis for Aptamers by End-Use - Pharma & Biotech Companies,
Academic & Government Research Institutes and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 125: Rest of Europe 8-Year Perspective for Aptamers by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Government Research Institutes
and Other End-Uses for the Years 2023 & 2030

ASIA-PACIFIC
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Asia-Pacific for 2023 (E)
Table 126: Asia-Pacific Recent Past, Current & Future Analysis
for Aptamers by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ for Years 2022 through 2030 and % CAGR

Table 127: Asia-Pacific 8-Year Perspective for Aptamers by
Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2023 & 2030

Table 128: Asia-Pacific Recent Past, Current & Future Analysis
for Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA
Aptamers - Independent Analysis of Annual Sales in US$ for the
Years 2022 through 2030 and % CAGR

Table 129: Asia-Pacific 8-Year Perspective for Aptamers by Type -
Percentage Breakdown of Value Sales for DNA Aptamers, XNA
Aptamers and RNA Aptamers for the Years 2023 & 2030

Table 130: Asia-Pacific Recent Past, Current & Future Analysis
for Aptamers by Technology - SELEX and Other Technologies -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 131: Asia-Pacific 8-Year Perspective for Aptamers by
Technology - Percentage Breakdown of Value Sales for SELEX and
Other Technologies for the Years 2023 & 2030

Table 132: Asia-Pacific Recent Past, Current & Future Analysis
for Aptamers by Application - Therapeutics Development,
Research & Development, Diagnostics and Other Applications -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 133: Asia-Pacific 8-Year Perspective for Aptamers by
Application - Percentage Breakdown of Value Sales for
Therapeutics Development, Research & Development, Diagnostics
and Other Applications for the Years 2023 & 2030

Table 134: Asia-Pacific Recent Past, Current & Future Analysis
for Aptamers by End-Use - Pharma & Biotech Companies, Academic &
Government Research Institutes and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 135: Asia-Pacific 8-Year Perspective for Aptamers by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Government Research Institutes
and Other End-Uses for the Years 2023 & 2030

AUSTRALIA
Aptamers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Australia for 2023 (E)
Table 136: Australia Recent Past, Current & Future Analysis for
Aptamers by Type - DNA Aptamers, XNA Aptamers and RNA Aptamers -
Independent Analysis of Annual Sales in US$ for the Years

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05797918/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001